Exagen
XGN

Exagen (XGN) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BTIGMaintainedBuy$9.00 from $8.00Aug 5, 2026
B. Riley SecuritiesMaintainedBuy$12.00 from $8.00Aug 5, 2026
TD CowenMaintainedBuy$10.00 from $8.00Aug 5, 2026
Roth CapitalInitiated CoverageBuy$8.00Jun 25, 2026
BTIGMaintainedBuy$8.00 from $9.00May 12, 2026
Canaccord GenuityMaintainedBuy$8.00 from $10.00Apr 20, 2026
KeybancMaintainedOverweight$10.00 from $15.00Mar 11, 2026
Craig-HallumMaintainedBuy$10.00 from $12.00Mar 11, 2026
Canaccord GenuityMaintainedBuy$10.00 from $15.00Mar 11, 2026
BTIGMaintainedBuy$9.00 from $10.00Mar 10, 2026
TD CowenMaintainedBuy$10.00 from $13.00Feb 24, 2026
BTIGMaintainedBuy$10.00 from $15.00Feb 17, 2026
B. Riley SecuritiesMaintainedBuy$8.00 from $18.00Jan 30, 2026
BTIGMaintainedBuy$15.00 from $13.00Nov 10, 2025
B. Riley SecuritiesMaintainedBuy$18.00 from $15.00Nov 5, 2025
Canaccord GenuityMaintainedBuy$15.00 from $11.00Oct 27, 2025
BTIGMaintainedBuy$13.00 from $11.00Oct 22, 2025
KeybancMaintainedOverweight$15.00 from $12.00Oct 14, 2025
B. Riley SecuritiesInitiated CoverageBuy$15.00Sep 11, 2025
Canaccord GenuityMaintainedBuy$11.00 from $8.00Jul 30, 2025

Frequently asked questions

  • What is the latest analyst rating on XGN?

    On Aug 5, 2026, BTIG maintained Exagen at Buy with a price target of $9.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.